Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Brain Cancer treatment details. Immunotherapy. China Medical University and Hospital, Taichung, Taiwan Region

Survival: 17.1 months
Toxicity Grade: 4
Treatments: Immunotherapy
Country: Taiwan Region
City/State/Province: Taichung
Hospital: China Medical University and Hospital
Journal: Link
Date: 8/2011

This study involved 17 malignant glioma patients with an average age of 44.7 years; 8 were male.

Patients were treated with an autologous dendritic cell tumor vaccine, which is an immunotherapy agent. For this treatment, immune cells (dendritic cells) are removed from a patientís blood sample, treated in a laboratory, and then injected back into the patient in order to cause an anti-tumor immune response.

Grade 4 lymphopenia was the most severe reported adverse event. Liver toxicity was also reported.

The median overall survival was 17.1 months.

Correspondence: Dr. Wen-Kuang Yang; email:

E-mail to a Friend Email Physician More Information